Anzeige
Mehr »
Dienstag, 21.07.2026 - Börsentäglich über 12.000 News
+50% in 13 Tagen - Steht der große Ausbruch jetzt bevor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiNo patent protection for Stelara? No problem for J&J as Tremfya fills the void
MiBuzzy Veradermics shows its oral minoxidil can tackle female pattern hair loss, too
MiKelun scores sac-TMT win in first-line NSCLC population missing from Merck's massive phase 3 program
MiSanofi teams up with Special Olympics Unified Football World, raises respiratory health awareness
14.07.With FDA approval for its breast cancer blockbuster hopeful, Celcuity could 'belong in the hands' of a Big Pharma
14.07.Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
14.07.Inside agency view: Havas SO on authenticity, connection and pushing back against the 'sea of sameness'
14.07.Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
14.07.AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
14.07.Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
13.07.FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
13.07.Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
13.07.GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
13.07.Germany pushes through healthcare reform package despite pharma's drug discount resistance
10.07.Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
10.07.Young people living with PKU take the mic in BioMarin podcast series, TikTok push
10.07.Apollo inks €3B equity deal for stake in Bayer's contraceptives business
10.07.FDA rejects Hengrui, Elevar's PD-1 liver cancer combo for a 3rd time
10.07.Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
10.07.Fierce Pharma Asia-More AstraZeneca China deals; Kailera, Hengrui's oral GLP-1 data; Scrutiny of Chinese trials
10.07.J&J's Tremfya retakes ad spending throne in June as Haleon tops pharma's World Cup airings
09.07.AstraZeneca, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
09.07.In compensation push, HHS gears up to draft COVID vaccine injury table
09.07.Ipsen's Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
09.07.Novo Nordisk asks public to 'Meet Me in the Middle' in new obesity experience installation